HOME >> BIOLOGY >> NEWS
Major grants support immunology, transplant and diabetes research at the University of Chicago

At a campus press briefing on October 6, the Juvenile Diabetes Foundation (JDF) and the National Institute of Allergy and Infectious Diseases (NIAID) announced two major, closely related, multi-year grants to research teams headquartered at the University of Chicago.

The JDF has awarded $7.5 million over a five-year period to establish the JDF Center for Islet Transplantation at the University of Chicago/University of Minnesota. The NIAID has launched a seven-year, $144-million initiative, involving nearly 40 research institutions to be known as the Collaborative Network for Clinical Research on Immune Tolerance.

Both projects will be directed by Jeffrey Bluestone, Ph.D., the Daniel K. Ludwig Professor of Pathology, Chairman of the Committee on Immunology and Director of the Ben May Institute for Cancer Research at the University of Chicago.

The JDF Center for Islet Transplantation, made possible by generous support from the McDonough Family Foundation in Chicago, will advance the use of transplants of insulin-producing pancreatic islets as a cure for diabetes. It will focus on finding new ways to prevent the body from rejecting islet transplants without causing dangerous side effects.

The Collaborative Network will concentrate on developing and testing new ways to induce immune tolerance by selectively modulating the immune system to inhibit harmful responses yet keep protective ones intact. This strategy promises to improve the success of transplants as well as treatments for autoimmune diseases such as type 1 diabetes, lupus and rheumatoid arthritis, which destroy the body's own cells.

"These are two vitally important, far-reaching and daring projects and we are pleased and honored that both will be based at the University of Chicago," said Glenn Steele, M.D., Ph.D., Dean of the Division of the Bio
'"/>

Contact: John Easton
jeaston@mcis.bsd.uchicago.edu
773-702-6241
University of Chicago Medical Center
6-Oct-1999


Page: 1 2 3 4

Related biology news :

1. Major scientific discovery in cancer research to be honored
2. Major U.S. environmental policy bears scrutiny in midlife
3. Major boost for European zebrafish research
4. Major mutations, not many small changes, might lead way to new species
5. Major new finding on genetics of Parkinsons disease zeroes in on activity of alpha synuclein
6. Major stress during pregnancy linked to autism
7. Major fossil find reveals Asian origins of salamanders
8. Major unique new study shows infrequent inspections lead to greater stream pollution
9. Major new initiative to resolve structure of protein families
10. Major air pollution study launched
11. Major grant to aid McGill University professors efforts to improve school science teaching

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2016)...   EyeLock LLC , a market leader of ... an IoT Center of Excellence in Austin, ... of embedded iris biometric applications. EyeLock,s iris ... security with unmatched biometric accuracy, making it the most ... EyeLock,s platform uses video technology to deliver a fast ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... 2016   EpiBiome , a precision microbiome engineering ... debt financing from Silicon Valley Bank (SVB). The financing ... advance its drug development efforts, as well as purchase ... "SVB has been an incredible strategic partner to us ... bank would provide," said Dr. Aeron Tynes Hammack ...
(Date:6/23/2016)... ... 23, 2016 , ... In a new case report published today in STEM ... who developed lymphedema after being treated for breast cancer benefitted from an injection of ... dealing with this debilitating, frequent side effect of cancer treatment. , Lymphedema ...
Breaking Biology Technology:
Cached News: